Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN1259941A details a streamlined route for 3-N,N-dicyclobutylamino-8-fluoro-benzopyran derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN115232071B details zinc-catalyzed quinoline synthesis replacing gold catalysts. Offers scalable cost reduction and high purity for pharmaceutical intermediates manufacturing supply chains.
Advanced esterification process for Metronidazole Benzoate yielding 91.5-95%. Offers significant cost reduction in pharma manufacturing through efficient solvent recycling.
Novel palladium-free synthesis of 3-methylbenzo[d]oxazol-2(3H)-one-5-boronic acid pinacol ester. High purity >99%, total yield >81%, cost-effective API intermediate manufacturing.
Novel radical reaction method for high-purity enaminone derivatives offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Novel MOF-Cu catalyzed Ugi reaction for high-purity dipeptide intermediates. Cost-effective, scalable synthesis with reusable catalyst for pharmaceutical applications.
Patent CN111170847B reveals a cyanide-free route for Drotaverine intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain safety.
Novel nickel-catalyzed route for Flindokalner racemate offers safer, scalable production. Ideal for neuroprotective drug supply chains seeking cost efficiency.
Patent CN108440623A reveals a novel silylation-free route for Capecitabine Intermediate. Achieve higher purity and reduced manufacturing costs with scalable supply.
Patent CN109761975B reveals a catalyst-free aminomethylation route for imidazoheteroaryls, offering significant cost reduction and simplified purification for pharmaceutical intermediate manufacturing.
Novel copper-catalyzed method converts tert-butyl isonitrile to amidines. Reduces costs and simplifies supply chain for pharmaceutical intermediate manufacturing.
Patent CN105273006B details a high-yield synthesis route for advanced ligands. This method ensures high purity and simplified processing for reliable pharmaceutical intermediates supply chains.
Patent CN104109174B introduces a novel ligand for asymmetric methoxycarbonylation, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply reliability.
Novel amide solvent method ensures high purity for Abemaciclib intermediate. Reduces impurities and simplifies supply chain for pharmaceutical manufacturing.
Patent CN114621128A reveals a novel TBS-protection strategy for (S)-oxiracetam, eliminating column chromatography to ensure >99.9% purity and significant cost reduction.
Patent CN101417910A details solid acid catalysis for prazole nitration, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel palladium-catalyzed route for baloxavir intermediate. Safer, scalable, cost-effective manufacturing solution for global supply chains.
Novel palladium-catalyzed quinazolinone synthesis offers high yield and scalable production capabilities for global pharmaceutical intermediates manufacturing supply chains.
Novel one-pot synthesis for 2-arylaminoacetamide compounds reduces hazardous waste and improves safety for scalable pharmaceutical intermediate manufacturing supply chains.
Novel catalytic amination process for ethacridine reduces waste and improves purity. Ideal for pharmaceutical supply chains seeking cost-effective API manufacturing solutions.